ENVALITH
H.U.グループホールディングス株式会社 logo

H.U. Group Holdings, Inc.

4544Prime MarketServices

H.U.グループホールディングス株式会社 logo
H.U. Group Holdings, Inc.4544
Reference Indicators

Market Cap

1,941¥100M

P/E (Forecast)

37.5x

P/B

1.4x

Dividend Yield (Forecast)

3.70%

ROE

5.0%

EV/EBITDA

7.8x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
272,944260,908236,950243,025247,362
Cost of Sales
161,145170,984173,715175,827175,977
Gross Profit
111,79989,92463,23567,19871,385
SG&A Expenses
61,30866,54367,27964,55766,605
Operating Income
50,49023,381-4,0432,6404,780
Non-operating Income
1,6931,4261,8894,283856
Non-operating Expenses
4,7612,7975,0862,1812,802
Ordinary Income
47,42222,010-7,2414,7422,834
Extraordinary Income
2743,4221,8535946,844
Extraordinary Losses
6,3732,5252,2312,1221,096
Pre-tax Income
41,32322,907-7,6193,2158,582
Income Taxes
11,7107,230-664831,877
Net Income
29,59915,676-7,5532,7616,823
EBITDA
65,11643,07516,82723,38626,537
Gross Margin
41.0%34.5%26.7%27.7%28.9%
Operating Margin
18.5%9.0%-1.7%1.1%1.9%
ROA
10.3%5.3%-2.6%1.0%2.6%
ROE
23.2%10.8%-5.8%2.0%5.0%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
検査・関連サービス事業157,297310.0%
臨床検査薬事業60,7359,05014.9%
ヘルスケア関連サービス事業29,3301,7596.0%